News & Analysis on Clinical Trial Services & Contract Research And Development
Metrohm has launched a new generation of its Capsule and Tablet Analysis System (CTAS), a unit designed specifically for making and testing solid dosage samples, claiming the system saves laboratory personnel time as well as improving reproducibility...
Innov-X Systems has launched a range of handheld analysers, claimed to be the smallest and lightest tube-based X-ray fluoroscopy spectrometers available, reports Phil Taylor.
Novartis has acquired a global license to a combination drug and inhaler device for chronic obstructive pulmonary disease (COPD) in one of the largest deals signed by the UK biotechnology sector, reports Phil Taylor.
Agilent has launched a Laboratory Resource Management (LRM) service for life science and pharmaceutical laboratories that promises to improve productivity, reduce service costs and simplfy administration.
Novartis has announced the formation of an alliance between Vectura Group and Arakis to develop and commercialise AD 237, a novel, long acting, antimuscarinic agent, for the treatment of chronic obstructive pulmonary disease (COPD).
Culture media supplier Oxoid has expanded the use of innovative chromogenicsubstrates within its chromogenic media range to provide clearly visibleanswers on a single culture plate.
Scientists have hailed an experimental drug, which fights tumours linked to two faulty genes in breast cancer, as a breakthrough in the fight against cancer. Animal tests have shown the drug prevents the growth of tumours so effectively that clinical...
Dutch biotechnology company Crucell has won a €21.4 million contract to produce a vaccine against Ebola for the US government's Vaccine Research Centre, reports Phil Taylor.
Bio-Rad Laboratories offer to buy BioSource International for approximately $82 million (€64m) has been rejected again after BioSource directors concluded that the proposed price was significantly below BioSource's inherent value.